Arent Fox LLP is pleased to announce the addition of intellectual property litigation partner Arthur S. Beeman, counsel Joel T. Muchmore, and health care administrative law counsel Steven V. Schnier to its new San Francisco office and its nationally recognized Intellectual Property, Complex Litigation, and Health Care practices.
Tags: Holland & Hart LLP | San FranciscoVeteran Trial and Financial Services Attorney Peter Obstler Joins Arnold & Porter
Arnold & Porter LLP announced today that Peter Obstler has joined the firm’s San Francisco office as a partner in the Litigation, Financial Services, and Securities and Enforcement practices. Also joining the firm with Mr. Obstler as counsel are Jee Young You and Marjory Gentry.
Tags: Arnold & Porter Kaye Scholer LLP | San FranciscoAntitrust Partner Rejoins Perkins Coie
Perkins Coie is pleased to announce that David Chiappetta has rejoined the firm as a partner in the Litigation practice. Chiappetta returns to Perkins Coie from Corrs Chambers Westgarth in Melbourne, Australia, where he prosecuted antitrust and consumer protection cases on behalf of the Australian Competition and Consumer Commission (ACCC), the Australian government’s competition watchdog.
Tags: Perkins Coie LLP | San FranciscoProminent Exempt Organizations and Tax Attorney Cynthia Rowland Joins Farella Braun + Martel as Partner
Farella Braun + Martel LLP welcomes San Francisco exempt organizations and tax attorney Cynthia R. Rowland to its partnership effective July 1.
Tags: Farella Braun + Martel LLP | San FranciscoGoodwin Procter Expands Life Sciences Practice with Addition of Karen Spindler in San Francisco Office
Goodwin Procter, a national Am Law 50 firm, announced today that Karen A. Spindler has joined the firm’s San Francisco office as a partner in its Life Sciences Practice. She will focus on advising life sciences companies and investors on a variety of intellectual property transactions. Spindler joins Goodwin from Kirkland & Ellis where she was a partner in its Palo Alto and San Francisco offices.
Tags: Goodwin Procter LLP | San FranciscoSchiff Hardin LLP Welcomes Kevin C. Trock as a Partner in the Intellectual Property Group
Kevin C. Trock has joined the Schiff Hardin LLP San Francisco office as a partner in the Intellectual Property Group from Alston & Bird LLP.
Tags: Schiff Hardin LLP | San FranciscoPatrick Ryan Joins Jeffer Mangels Butler & Mitchell LLP as Chairman of the Firm’s Antitrust Group
Commercial trial lawyer Patrick M. Ryan has joined Jeffer Mangels Butler & Mitchell LLP (JMBM) as a partner and will head the Firm’s Antitrust Practice Group. Previously with Morgan Lewis, Ryan has significant expertise in complex commercial litigation including antitrust, class action, intellectual property, anti-counterfeiting/supply chain, and constitutional matters.
Tags: Jeffer Mangels & Mitchell LLP | San FranciscoPerkins Coie’s San Francisco Office Adds Real Estate Pro
Perkins Coie is pleased to announce that Allan E. Low has joined the firm’s San Francisco office as a partner in the Real Estate practice. Low was most recently a partner at Nixon Peabody LLP.
Tags: Perkins Coie LLP | San FranciscoDouglas Bria Joins Littler Mendelson’s Expanding San Francisco Office
Douglas Bria has joined Littler Mendelson, P.C. (Littler), the world’s largest employment and labor law firm representing management, as a shareholder in the San Francisco office. Bria, previously a partner in Jackson Lewis LLP’s San Francisco office, has extensive experience in employment litigation matters, including class actions and complex litigation, e-Discovery, general employment litigation and wage and hour compliance. Bria’s arrival coincides with the addition of another former Jackson Lewis partner, JoAnna Brooks, who also joined Littler last week.
Tags: Littler Mendelson P.C. | San FranciscoCooley Advises Underwriters on Epizyme, Inc. Initial Public Offering
Cooley LLP announced today that it advised the underwriters on Epizyme, Inc.’s recent IPO. Epizyme, now trading on the NASDAQ Global Stock Market under the symbol “EPZM,” is a Massachusetts-based biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers.
Tags: Cooley LLP | San Francisco








